U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pyruvate kinase deficiency of red cells(CNSHA2)

MedGen UID:
473069
Concept ID:
C0340968
Disease or Syndrome
Synonyms: CNSHA2; PK deficiency; Pyruvate kinase deficiency; PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE; Pyruvate kinase deficiency of erythrocytes; Pyruvate kinase deficiency, Amish type
SNOMED CT: PK - Pyruvate kinase deficiency (124331002); Pyruvate kinase deficiency (124331002); Deficiency of phosphoenolpyruvate kinase (124331002); Deficiency of phosphoenol transphosphorylase (124331002); Deficiency of pyruvate kinase (124331002)
Modes of inheritance:
Autosomal recessive inheritance
MedGen UID:
141025
Concept ID:
C0441748
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele).
 
Gene (location): PKLR (1q22)
 
Monarch Initiative: MONDO:0009950
OMIM®: 266200
Orphanet: ORPHA766

Definition

Red cell pyruvate kinase deficiency, or congenital nonspherocytic hemolyic anemia-2 (CNSHA2), is the most common cause of hereditary nonspherocytic hemolytic anemia. PK deficiency is also the most frequent enzyme abnormality of the glycolytic pathway (Zanella et al., 2005). [from OMIM]

Additional description

From MedlinePlus Genetics
Pyruvate kinase deficiency is an inherited disorder that affects red blood cells, which carry oxygen to the body's tissues. People with this disorder have a condition known as chronic hemolytic anemia, in which red blood cells are broken down (undergo hemolysis) prematurely, resulting in a shortage of red blood cells (anemia). Specifically, pyruvate kinase deficiency is a common cause of a type of inherited hemolytic anemia called hereditary nonspherocytic hemolytic anemia. In hereditary nonspherocytic hemolytic anemia, the red blood cells do not assume a spherical shape as they do in some other forms of hemolytic anemia.

Chronic hemolytic anemia can lead to unusually pale skin (pallor), yellowing of the eyes and skin (jaundice), extreme tiredness (fatigue), shortness of breath (dyspnea), and a rapid heart rate (tachycardia). An enlarged spleen (splenomegaly), an excess of iron in the blood, and small pebble-like deposits in the gallbladder or bile ducts (gallstones) are also common in this disorder.

In people with pyruvate kinase deficiency, hemolytic anemia and associated complications may range from mild to severe. Some affected individuals have few or no symptoms. Severe cases can be life-threatening in infancy, and such affected individuals may require regular blood transfusions to survive. The symptoms of this disorder may get worse during an infection or pregnancy.  https://medlineplus.gov/genetics/condition/pyruvate-kinase-deficiency

Clinical features

From HPO
Fetal growth restriction
MedGen UID:
4693
Concept ID:
C0015934
Pathologic Function
An abnormal restriction of fetal growth with fetal weight below the tenth percentile for gestational age.
Cholecystitis
MedGen UID:
920
Concept ID:
C0008325
Disease or Syndrome
The presence of inflammatory changes in the gallbladder.
Cholelithiasis
MedGen UID:
3039
Concept ID:
C0008350
Disease or Syndrome
Hard, pebble-like deposits that form within the gallbladder.
Hepatomegaly
MedGen UID:
42428
Concept ID:
C0019209
Finding
Abnormally increased size of the liver.
Jaundice
MedGen UID:
43987
Concept ID:
C0022346
Sign or Symptom
Yellow pigmentation of the skin due to bilirubin, which in turn is the result of increased bilirubin concentration in the bloodstream.
Erythroid hyperplasia
MedGen UID:
4536
Concept ID:
C0014800
Disease or Syndrome
Increased count of erythroid precursor cells, that is, erythroid lineage cells in the bone marrow.
Reticulocytosis
MedGen UID:
60089
Concept ID:
C0206160
Finding
An elevation in the number of reticulocytes (immature erythrocytes) in the peripheral blood circulation.
Chronic hemolytic anemia
MedGen UID:
237230
Concept ID:
C1387532
Disease or Syndrome
An chronic form of hemolytic anemia.
Increased red cell osmotic fragility
MedGen UID:
376594
Concept ID:
C1849478
Finding
Decreased hemoglobin concentration
MedGen UID:
1670936
Concept ID:
C4732750
Finding
An abnormal reduction below normal hemoglobin concentration in the circulation.
Splenomegaly
MedGen UID:
52469
Concept ID:
C0038002
Finding
Abnormal increased size of the spleen.
Unconjugated hyperbilirubinemia
MedGen UID:
82786
Concept ID:
C0268306
Disease or Syndrome
An increased amount of unconjugated (indirect) bilurubin in the blood.
Reduced red cell pyruvate kinase level
MedGen UID:
1369680
Concept ID:
C4476595
Finding
Decrease in the level of pyruvate kinase (PK) within erythrocytes. PK catalyzes the reaction
Reduced haptoglobin level
MedGen UID:
1686017
Concept ID:
C5209264
Finding
An abnormally low concentration of haptoglobin in the blood circulation. Decreased haptoglobin in conjunction with increased reticulocyte count and anemia may indicate hemolysis. Decreased haptoglobin levels can also occur in the absence of hemolysis, due to cirrhosis of the liver, disseminated ovarian carcinomatosis, pulmonary sarcoidosis, and elevated estrogen state.
Pallor
MedGen UID:
10547
Concept ID:
C0030232
Finding
Abnormally pale skin.
Non-immune hydrops fetalis
MedGen UID:
105327
Concept ID:
C0455988
Disease or Syndrome
Hydrops fetalis is a descriptive term for generalized edema of the fetus, with fluid accumulation in extravascular components and body cavities. It is not a diagnosis in itself, but a symptom and end-stage result of a wide variety of disorders. In the case of immune hydrops fetalis, a frequent cause is maternofetal incompatibility as in that related to a number of genetic anemias and metabolic disorders expressed in the fetus; in other instances, it remains idiopathic and likely multifactorial (summary by Bellini et al., 2009). Nonimmune hydrops fetalis accounts for 76 to 87% of all described cases of hydrops fetalis (Bellini et al., 2009). Genetic Heterogeneity of Hydrops Fetalis In southeast Asia, alpha-thalassemia (604131) is the most common cause of hydrops fetalis, accounting for 60 to 90% of cases. Almost all of these cases result from homozygous deletion of the HBA1 (141800) and HBA2 (141850) genes. A few cases have been reported that had 1 apparently normal alpha-globin gene, termed the hemoglobin H (613978) hydrops fetalis syndrome (summary by Chui and Waye, 1998). Other genetic disorders predisposing to NIHF include other congenital anemias, such as erythropoietic porphyria (e.g., 606938.0013), and many metabolic disorders, such as one form of Gaucher disease (e.g., 606463.0009), infantile sialic acid storage disease (269920), mucopolysaccharidosis type VII (253220), glycogen storage disease IV (232500), congenital disorder of glycosylation type Ia (212065), and disorders of lymphatic malformation (see, e.g., LMPHM1, 153100).

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPyruvate kinase deficiency of red cells

Professional guidelines

PubMed

Al-Samkari H, Shehata N, Lang-Robertson K, Bianchi P, Glenthøj A, Sheth S, Neufeld EJ, Rees DC, Chonat S, Kuo KHM, Rothman JA, Barcellini W, van Beers EJ, Pospíšilová D, Shah AJ, van Wijk R, Glader B, Mañú Pereira MDM, Andres O, Kalfa TA, Eber SW, Gallagher PG, Kwiatkowski JL, Galacteros F, Lander C, Watson A, Elbard R, Peereboom D, Grace RF
Lancet Haematol 2024 Mar;11(3):e228-e239. Epub 2024 Feb 5 doi: 10.1016/S2352-3026(23)00377-0. PMID: 38330977
Johnson S, Grace RF, Despotovic JM
Pediatr Blood Cancer 2022 Aug;69(8):e29696. Epub 2022 Apr 22 doi: 10.1002/pbc.29696. PMID: 35452178
Grace RF, Barcellini W
Blood 2020 Sep 10;136(11):1241-1249. doi: 10.1182/blood.2019000945. PMID: 32702739

Recent clinical studies

Etiology

Grace RF
Hematology Am Soc Hematol Educ Program 2023 Dec 8;2023(1):97-106. doi: 10.1182/hematology.2023000466. PMID: 38066940Free PMC Article
Johnson S, Grace RF, Despotovic JM
Pediatr Blood Cancer 2022 Aug;69(8):e29696. Epub 2022 Apr 22 doi: 10.1002/pbc.29696. PMID: 35452178
Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ; ACTIVATE Investigators
N Engl J Med 2022 Apr 14;386(15):1432-1442. doi: 10.1056/NEJMoa2116634. PMID: 35417638
Chonat S, Eber SW, Holzhauer S, Kollmar N, Morton DH, Glader B, Neufeld EJ, Yaish HM, Rothman JA, Sharma M, Ravindranath Y, Wang H, Breakey VR, Sheth S, Bradeen HA, Al-Sayegh H, London WB, Grace RF
Pediatr Blood Cancer 2021 Sep;68(9):e29148. Epub 2021 Jun 14 doi: 10.1002/pbc.29148. PMID: 34125488
Jamwal M, Sharma P, Das R
Indian J Pediatr 2020 Jan;87(1):66-74. Epub 2019 Dec 10 doi: 10.1007/s12098-019-03119-8. PMID: 31823208

Diagnosis

Al-Samkari H, Shehata N, Lang-Robertson K, Bianchi P, Glenthøj A, Sheth S, Neufeld EJ, Rees DC, Chonat S, Kuo KHM, Rothman JA, Barcellini W, van Beers EJ, Pospíšilová D, Shah AJ, van Wijk R, Glader B, Mañú Pereira MDM, Andres O, Kalfa TA, Eber SW, Gallagher PG, Kwiatkowski JL, Galacteros F, Lander C, Watson A, Elbard R, Peereboom D, Grace RF
Lancet Haematol 2024 Mar;11(3):e228-e239. Epub 2024 Feb 5 doi: 10.1016/S2352-3026(23)00377-0. PMID: 38330977
Bianchi P, Fermo E
Haematologica 2020 Sep 1;105(9):2218-2228. doi: 10.3324/haematol.2019.241141. [Epub ahead of print] PMID: 33054047Free PMC Article
Grace RF, Barcellini W
Blood 2020 Sep 10;136(11):1241-1249. doi: 10.1182/blood.2019000945. PMID: 32702739
Jamwal M, Sharma P, Das R
Indian J Pediatr 2020 Jan;87(1):66-74. Epub 2019 Dec 10 doi: 10.1007/s12098-019-03119-8. PMID: 31823208
Haley K
Med Clin North Am 2017 Mar;101(2):361-374. Epub 2016 Dec 8 doi: 10.1016/j.mcna.2016.09.008. PMID: 28189176

Therapy

Zhuang-Yan A, Shirley M
Drugs 2023 Nov;83(17):1613-1620. Epub 2023 Nov 22 doi: 10.1007/s40265-023-01961-x. PMID: 37991635
Pilo F, Angelucci E
Drugs Today (Barc) 2023 Mar;59(3):125-134. doi: 10.1358/dot.2023.59.3.3521880. PMID: 36847623
Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ; ACTIVATE Investigators
N Engl J Med 2022 Apr 14;386(15):1432-1442. doi: 10.1056/NEJMoa2116634. PMID: 35417638
Grace RF, Barcellini W
Blood 2020 Sep 10;136(11):1241-1249. doi: 10.1182/blood.2019000945. PMID: 32702739
Grace RF, Glader B
Pediatr Clin North Am 2018 Jun;65(3):579-595. doi: 10.1016/j.pcl.2018.02.005. PMID: 29803284

Prognosis

Grace RF, van Beers EJ, Vives Corrons JL, Glader B, Glenthøj A, Kanno H, Kuo KHM, Lander C, Layton DM, Pospíŝilová D, Viprakasit V, Li J, Yan Y, Boscoe AN, Bowden C, Bianchi P
BMJ Open 2023 Mar 23;13(3):e063605. doi: 10.1136/bmjopen-2022-063605. PMID: 36958777Free PMC Article
Mehrabi Sisakht J, Mehri M, Najmabadi H, Azarkeivan A, Neishabury M
Arch Iran Med 2022 Oct 1;25(10):691-697. doi: 10.34172/aim.2022.108. PMID: 37542401Free PMC Article
Johnson S, Grace RF, Despotovic JM
Pediatr Blood Cancer 2022 Aug;69(8):e29696. Epub 2022 Apr 22 doi: 10.1002/pbc.29696. PMID: 35452178
Grace RF, Rose C, Layton DM, Galactéros F, Barcellini W, Morton DH, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM, Sheth S, Kwiatkowski JL, Barbier AJ, Bodie S, Silver B, Hua L, Kung C, Hawkins P, Jouvin MH, Bowden C, Glader B
N Engl J Med 2019 Sep 5;381(10):933-944. doi: 10.1056/NEJMoa1902678. PMID: 31483964
Grace RF, Bianchi P, van Beers EJ, Eber SW, Glader B, Yaish HM, Despotovic JM, Rothman JA, Sharma M, McNaull MM, Fermo E, Lezon-Geyda K, Morton DH, Neufeld EJ, Chonat S, Kollmar N, Knoll CM, Kuo K, Kwiatkowski JL, Pospíšilová D, Pastore YD, Thompson AA, Newburger PE, Ravindranath Y, Wang WC, Wlodarski MW, Wang H, Holzhauer S, Breakey VR, Kunz J, Sheth S, Rose MJ, Bradeen HA, Neu N, Guo D, Al-Sayegh H, London WB, Gallagher PG, Zanella A, Barcellini W
Blood 2018 May 17;131(20):2183-2192. Epub 2018 Mar 16 doi: 10.1182/blood-2017-10-810796. PMID: 29549173

Clinical prediction guides

Zhuang-Yan A, Shirley M
Drugs 2023 Nov;83(17):1613-1620. Epub 2023 Nov 22 doi: 10.1007/s40265-023-01961-x. PMID: 37991635
Grace RF, van Beers EJ, Vives Corrons JL, Glader B, Glenthøj A, Kanno H, Kuo KHM, Lander C, Layton DM, Pospíŝilová D, Viprakasit V, Li J, Yan Y, Boscoe AN, Bowden C, Bianchi P
BMJ Open 2023 Mar 23;13(3):e063605. doi: 10.1136/bmjopen-2022-063605. PMID: 36958777Free PMC Article
Secrest MH, Storm M, Carrington C, Casso D, Gilroy K, Pladson L, Boscoe AN
Eur J Haematol 2020 Aug;105(2):173-184. Epub 2020 Jun 23 doi: 10.1111/ejh.13424. PMID: 32279356Free PMC Article
Grace RF, Rose C, Layton DM, Galactéros F, Barcellini W, Morton DH, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM, Sheth S, Kwiatkowski JL, Barbier AJ, Bodie S, Silver B, Hua L, Kung C, Hawkins P, Jouvin MH, Bowden C, Glader B
N Engl J Med 2019 Sep 5;381(10):933-944. doi: 10.1056/NEJMoa1902678. PMID: 31483964
Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B
Am J Hematol 2015 Sep;90(9):825-30. Epub 2015 Aug 14 doi: 10.1002/ajh.24088. PMID: 26087744Free PMC Article

Recent systematic reviews

Secrest MH, Storm M, Carrington C, Casso D, Gilroy K, Pladson L, Boscoe AN
Eur J Haematol 2020 Aug;105(2):173-184. Epub 2020 Jun 23 doi: 10.1111/ejh.13424. PMID: 32279356Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...